APA (7th ed.) Citation

CL, L., M, F., KW, B., GT, M., CDJ, O., PQ, D., . . . VC, T. (2024). Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications. Cancers, 16(16), . https://doi.org/10.3390/cancers16162878

Chicago Style (17th ed.) Citation

CL, Lee, et al. "Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications." Cancers 16, no. 16 (2024). https://doi.org/10.3390/cancers16162878.

MLA (9th ed.) Citation

CL, Lee, et al. "Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications." Cancers, vol. 16, no. 16, 2024, https://doi.org/10.3390/cancers16162878.